AH-D-peptide

AH-D peptide is an antiviral peptide that selectively disrupts membrane structures within the size range of exosomes, inducing T-EXO depletion and enhancing cancer immunotherapy[1].

12352209

Virus Protease

Anti-infection

Cancer-programmed cell death

Cancer; Infection

99.32

DMSO : 100 mg/mL (ultrasonic)

O=C(NCC(N[C@H](CO)C(N[C@H](CC1=CNC2=CC=CC=C12)C(N[C@H](CC(C)C)C(N[C@H](CCCNC(N)=N)C(N[C@H](CC(O)=O)C(N[C@H](C(C)C)C(N[C@H](CC3=CNC4=CC=CC=C34)C(N[C@H](CC(O)=O)C(N[C@H](CC5=CNC6=CC=CC=C56)C(N[C@H]([C@H](C)CC)C(N[C@H](CS)C(N[C@H]([C@@H](O)C)C(N[C@H](C(C)C)C(N[C@H](CC(C)C)C(N[C@H]([C@@H](O)C)C(N[C@H](CC(O)=O)C(N[C@H](CC7=CC=CC=C7)C(N[C@H](CCCCN)C(N[C@H]([C@@H](O)C)C(N[C@H](CC8=CNC9=CC=CC=C89)C(N[C@H](CC(C)C)C(N[C@H](CCC(N)=O)C(N[C@H](CO)C(N[C@H](CCCCN)C(N[C@H](CC(C)C)C(N)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@@H](CO)N

C154H228N38O40S

3283.75

[1]Sol Shin, et al. Curvature-sensing peptide inhibits tumour-derived exosomes for enhanced cancer immunotherapy. Nat Mater. 2023 May;22 (5) :656-665.

Blue Ice

-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)

http://file.medchemexpress.com/batch_PDF/HY-P10862/AH-D-peptide-SDS-MedChemExpress.pdf

Peptides

No Development Reported